Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy-naive”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07333287
What this trial is testing

Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Who this might be right for
Pancreatic Cancer Liver MetastasesImmunotherapy-naive
Shandong Provincial Hospital 38
Large-scale testing (Phase 3)Active Not RecruitingNCT03391869
What this trial is testing

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung AdenocarcinomaLung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
M.D. Anderson Cancer Center 339
Testing effectiveness (Phase 2)UnknownNCT03579654
What this trial is testing

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

Who this might be right for
Prostate Cancer
OncBioMune Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT04108026
What this trial is testing

Immunotherapy in Patient With Poor General Condition

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Intergroupe Francophone de Cancerologie Thoracique 50
Early research (Phase 1)Study completedNCT00110578
What this trial is testing

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT02692976
What this trial is testing

Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients

Who this might be right for
Prostatic NeoplasmsImmunotherapyDendritic Cells+1 more
Radboud University Medical Center 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03317158
What this trial is testing

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urothelial CarcinomaBladder Cancer
Noah Hahn, M.D. 186
Testing effectiveness (Phase 2)UnknownNCT05038657
What this trial is testing

Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).

Who this might be right for
Squamous Cell CarcinomaUrinary Tract Cancer
University Hospital Southampton NHS Foundation Trust 36
Large-scale testing (Phase 3)Study completedNCT03469960
What this trial is testing

Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Intergroupe Francophone de Cancerologie Thoracique 265
Early research (Phase 1)WithdrawnNCT06190249
What this trial is testing

Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma

Who this might be right for
Stage IIIB MelanomaStage IIIC MelanomaStage IIID Melanoma
James Isaacs, MD
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783581
What this trial is testing

Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial

Who this might be right for
Locally Advanced Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
Mayo Clinic 30
Early research (Phase 1)Study completedNCT03812549
What this trial is testing

Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients

Who this might be right for
Stage IV NSCLC
Sichuan University 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02138734
What this trial is testing

Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
ImmunityBio, Inc. 369
Testing effectiveness (Phase 2)UnknownNCT00258336
What this trial is testing

Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Favrille 56
Early research (Phase 1)Study completedNCT01675765
What this trial is testing

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 60
Large-scale testing (Phase 3)Study completedNCT00094458
What this trial is testing

Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC

Who this might be right for
Crohn Disease
Centocor Ortho Biotech Services, L.L.C. 508